Log in

CVE:ADKDiagnos Stock Price, Forecast & News

C$0.18
0.00 (0.00 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
C$0.18
Now: C$0.18
C$0.18
50-Day Range
C$0.16
MA: C$0.19
C$0.22
52-Week Range
C$0.10
Now: C$0.18
C$0.38
VolumeN/A
Average Volume53,408 shs
Market CapitalizationC$11.05 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
DIAGNOS Inc. provides software-based interpretation services primarily in Canada, the United Arab Emirates, Saudi Arabia, Slovakia, and the United States. It offers image analysis services through Computer Assisted Retinal Analysis, a software tool that assists health specialists in the detection of diabetic retinopathy. DIAGNOS Inc. has a collaboration agreement with ÉTS, École de technologie supérieure. The company was founded in 1998 and is headquartered in Brossard, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars


Industry, Sector and Symbol

Industry Health Information Services
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+1-450-6788882

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$344,989.00
Cash FlowC$0.01 per share
Book ValueC($0.01) per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$11.05 million
Next Earnings Date6/3/2020 (Estimated)
OptionableNot Optionable

Receive ADK News and Ratings via Email

Sign-up to receive the latest news and ratings for ADK and its competitors with MarketBeat's FREE daily newsletter.

Diagnos (CVE:ADK) Frequently Asked Questions

How has Diagnos' stock been impacted by COVID-19 (Coronavirus)?

Diagnos' stock was trading at C$0.22 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ADK stock has decreased by 18.2% and is now trading at C$0.18. View which stocks have been most impacted by Coronavirus.

When is Diagnos' next earnings date?

Diagnos is scheduled to release its next quarterly earnings announcement on Wednesday, June 3rd 2020. View our earnings forecast for Diagnos.

Has Diagnos been receiving favorable news coverage?

Media stories about ADK stock have been trending very negative recently, InfoTrie reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Diagnos earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days. View the latest news aboutDiagnos.

Who are some of Diagnos' key competitors?

What other stocks do shareholders of Diagnos own?

Who are Diagnos' key executives?

Diagnos' management team includes the following people:
  • Mr. André Larente, CEO, Pres & Exec. Director
  • Mr. Marc-André Massue, VP of Fin., CFO & Sec.
  • Mr. Guillermo Moreno Robles, VP of Sales
  • Dr. Hadi Chakor Djelthia, Chief Medical Officer

What is Diagnos' stock symbol?

Diagnos trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ADK."

How do I buy shares of Diagnos?

Shares of ADK and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Diagnos' stock price today?

One share of ADK stock can currently be purchased for approximately C$0.18.

How big of a company is Diagnos?

Diagnos has a market capitalization of C$11.05 million and generates C$344,989.00 in revenue each year.

What is Diagnos' official website?

The official website for Diagnos is www.diagnos.ca.

How can I contact Diagnos?

Diagnos' mailing address is 7005 Taschereau Blvd, Suite 340 Brossard, BROSSARD, QC J4Z 1A7, Canada. The company can be reached via phone at +1-450-6788882.

This page was last updated on 5/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.